Meridian Bioscience Stock

Meridian Bioscience Net Change in Cash

The Net Change in Cash of Meridian Bioscience (VIVO) as of Aug 17, 2026 is 31.68 M USD. In the previous year, Net Change in Cash was -3.74 M USD — a change of -946.43% (higher).

Net Change in Cash

31.68 MUSD

YoY

-946.43%

Last updated:

Net Change in Cash of Meridian Bioscience is 2026 31.68 M USD. Net Change in Cash of Meridian Bioscience was 2025 -3.74 M USD. It decreases by -946.43% higher compared to the previous year.
Access this data via the Eulerpool API

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meridian Bioscience stock

Net Change in Cash of Meridian Bioscience is 31.68 M USD in 2026.

Net Change in Cash of Meridian Bioscience changed from -3.74 M USD to 31.68 M USD, representing a -946.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash Meridian Bioscience since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Meridian Bioscience historically and in real time.

Access this data via the Eulerpool API

Cash Flow — Meridian Bioscience

All Key Metrics — Meridian Bioscience